Last edition
News about "chemotherapy "
Akeso Gets NMPA Approval of Penpulimab for Nasopharyngeal Cancer
With this new approval, penpulimab now provides comprehensive treatment coverage across all stages of NPC, offering patients a continuous immunotherapy option from first-line to third-line therapy.
Chemotherapy | 17/03/2025 | By Aishwarya
AstraZeneca India Secures CDSCO Approval for Durvalumab
AstraZeneca Pharma India has been granted permission to import for sale and distribution of Durvalumab 120 mg/2.4 mL and 500 mg/10 mL solution for infusion from the Central Drugs Standard Control Organisation (CDSCO).
Chemotherapy | 27/09/2024 | By Aishwarya | 123
Astellas Gets EU Approval for VYLOY in Combination with Chemotherapy
Astellas Pharma Inc. has announced that the European Commission (EC) has approved VYLOY (zolbetuximab) in combination with fluoropyrimidine- and platinum-containing chemotherapy.
Chemotherapy | 23/09/2024 | By Aishwarya | 192
AstraZeneca Completes Acquisition of Fusion
AstraZeneca has completed the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).
Chemotherapy | 06/06/2024 | By Aishwarya | 143
FDA Approves Amgen's IMDELLTRA for Advanced Small Cell Lung Cancer
The approval is based on the encouraging response rate and duration of response (DoR) observed in clinical studies, under the FDA's accelerated approval pathway.
Chemotherapy | 17/05/2024 | By Abha | 148
Lantern Pharma Gets Regulatory Approval to Expand Harmonic Clinical Trial for NSCLC
Lantern Pharma Inc. has secured regulatory approval to expand its Harmonic trial, a Phase 2 clinical study evaluating LP-300 in non-small cell lung cancer (NSCLC) in never-smokers in both Japan and Taiwan.
Chemotherapy | 23/04/2024 | By Aishwarya | 105
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy